Clinical Trials Details

GI Stromal Tumor (GIST)

A randomized, multi-center phase III study to evaluate the efficacy and safety of nilotinib versus imatinib in adult patients with unresectable or metastatic gastrointestinal stromal tumors (GIST).

Trial ID: 08055

Contact: Mindy Collard

Phone: (281)863-6686

Learn More about this trial.

go back | new search

This Study is currently being offered at the following Sites:

Practice	State/City
New York Oncology Hematology, P.C.	Albany, NY (Scotland)
New York Oncology Hematology, P.C.	Amsterdam, NY
Rocky Mountain Cancer Centers, LLP	Aurora, CO
Birmingham Hematology and Oncology Associates, LLC	Birmingham, AL (St. Vincent)
Rocky Mountain Cancer Centers, LLP	Boulder, CO (4715 Arapahoe)
Rocky Mountain Cancer Centers, LLP	Colorado Springs, CO
Rocky Mountain Cancer Centers, LLP	Colorado Springs, CO-Fontanero
Rocky Mountain Cancer Centers, LLP	Denver, CO (4700 Hale Parkway)
Rocky Mountain Cancer Centers, LLP	Denver, CO (Midtown)
Arizona Oncology Associates, PC - NAHOA	Flagstaff, AZ
Rocky Mountain Cancer Centers, LLP	Lakewood, CO (Van Gordon)
Rocky Mountain Cancer Centers, LLP	Littleton, CO (Dry Creek)
Rocky Mountain Cancer Centers, LLP	Lone Tree, CO (Sky Ridge)
Rocky Mountain Cancer Centers, LLP	Longmont, CO (2030 Mountain)
Ocala Oncology Center, P.L.	Ocala, FL
Rocky Mountain Cancer Centers, LLP	Parker, CO
Rocky Mountain Cancer Centers, LLP	Thornton, CO
Texas Oncology, P.A.	Tyler, TX